Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Diseases × Lead × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Brain Neoplasms 3 Neoplasms 2 Lung Neoplasms 2 Thrombophilia 1 Stomatitis 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Periodontitis 1 Patient Satisfaction 1 Neoplasms, Plasma Cell 1 Motor Activity 1 Liver Neoplasms 1 Liver Diseases 1 Head and Neck Neoplasms 1 Glioblastoma 1 Gastrointestinal Stromal Tumors 1 Febrile Neutropenia 1 EGFR-Mutant Lung Cancer 1 Deglutition Disorders 1 Communication Disorders 1 Colorectal Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Pancreatic Ductal 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Breast Diseases 1 Blood Coagulation Disorders 1 Adenocarcinoma 1

Interventions

Trastuzumab 7 Letrozole 7 Anastrozole 7 palbociclib 6 exemestane 6 Docetaxel 6 Fulvestrant 5 ribociclib 4 pyrotinib 4 entinostat 4 abemaciclib 4 Cyclophosphamide 4 Doxorubicin 3 pertuzumab 2 Sodium Chloride 2 Paclitaxel 2 Lapatinib 2 Gonadotropin-Releasing Hormone 2 Exercise 2 Everolimus 2 Epirubicin 2 Drug Evaluation 2 Capecitabine 2 Botulinum Toxins, Type A 2 Blood Specimen Collection 2 Aromatase Inhibitors 2 AZD9833 2 tucatinib 1 trastuzumab deruxtecan 1 taxane 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04842240 2021-04-13

PROM-Q

The Leeds Teaching Hospitals NHS Trust

Breast Diseases, Breast Neoplasms, Patient Satisfaction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡